Navigation Links
Eastern Clinical Trials Russia CRO Passes EMA Inspection
Date:2/12/2013

Moscow, Russia (PRWEB) February 12, 2013

Moscow, Russia January 31, 2013 -- Eastern Clinical Trials (ECT), a leading contract research organization (CRO) with operations in Russia and Central and Eastern Europe, announced today that it successfully passed with no major findings an inspection conducted by the European Medicines Agency (EMA).

The Inspection was conducted on 22-24 January 2013 at the site of Professor Sergey V. Orlov MD, PhD, of Saint Petersburg State Medical University, who is a principal investigator in a large registration oncology trial.

“We are very pleased to have passed the EMA Inspection” commented Dr. Svetlana Vodolazhskaya, Managing Director of Eastern Clinical Trials. “The Agency’s inspection results confirm that ECT's clinical research operations meet and often exceed international standards. We realize the importance of efficient operations that meet our client’s high requirements in drug development process and take great pride in both the quality of our work and in ECT's exceptional team of professionals.”

About Eastern Clinical Trials (ECT)(http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana.vodolazhskaya(at)easterntrials(dot)com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10421281.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
2. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
3. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
4. Galectin-3 Assessed as a Biomarker of Heart Failure: Key Clinical Trial Findings Published by Dove Medical Press
5. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
6. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
7. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
10. MC Leeuwarden Selects ClinicalKey
11. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, Hungary, ... be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has ... it now. , Biomarkers are components in the blood, tissue or body ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
Breaking Biology Technology:
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):